Explore significant advancements in clinical trial design to push medicinal phage therapies to the clinic, CRISPR-based gene editing to improve functionality, the rise of lytic technologies, and alternative potential for phage technologies beyond human health. This is the conference of the year for biopharma, clinicians and consumer product developers to harness the safety and efficacy of phages.

Whether you're at the forefront of the field or emerging into phage therapy for the first time, the 5th Bacteriophage Therapy Summit is the key networking platform that enables you to meaningfully apply phage science and prove commercial success.

Speakers: Bob Blasdel, Director - Research, Vesale Pharma , Danish Malik, Reader Industrial Biology, Loughborough University, Edward Burd, Senior Vice President Regulatory Affairs, BiomX, Iddo Nadav Weiner, Director and Head of Software, BiomX, Lorenzo Corsini, Co-Founder and Chief Executive Officer, Phagomed, Minmin Yen, Chief Executive Officer and Co-Founder, PhagePro, Vincent Fischetti, Professor and Head of Lab, The Rockefeller University Viviana Clavijo, Chief Executive Officer, Sciphage, Clara Leandro, Head of Infection, TechnoPhage SA, David Harper, Chief Executive Officer, etc.

Category: Conferences | Science, Health and Medicine | Pharmaceuticals | Drug Discovery

Date and Time: 21st February 2023 at 9:00 am to 23rd February 2023 at 5:00 pm

Read on bacteriophage-summit.com

Continue reading at bacteriophage-summit.com

Biosimilar Pharmaceuticals

Facebook Share

Twitter Share

Linkedin Share

Email Share